PDCD1 and posterior cortical atrophy: In an immunotherapy cohort which collected pre‐ and post‐treatment PCa samples [51], the combination therapy of ADT and anti‐PD‐1 resulted in an increase in the proportion of CD8+ T cells and a decrease in the proportion of monocytes and macrophages (Figure 8a–b).